Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 18:13:970854.
doi: 10.3389/fgene.2022.970854. eCollection 2022.

Fasting glucose mediates the influence of genetic variants of SOD2 gene on lean non-alcoholic fatty liver disease

Na Wu  1   2 , Xiangyu Zhai  3 , Fan Yuan  2 , Jie Li  1 , Ning Yu  1 , Fengwei Zhang  1 , Dong Li  4 , Jianying Wang  1 , Lei Zhang  1 , Yi Shi  2 , Guang Ji  5 , Guang He  2 , Baocheng Liu  1
Affiliations

Fasting glucose mediates the influence of genetic variants of SOD2 gene on lean non-alcoholic fatty liver disease

Na Wu et al. Front Genet. .

Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) imposes an enormous burden on public health, and a large proportion of NAFLD patients are lean with normal body weight, which is rarely mentioned. We conducted this study to determine the mediation effects of fasting glucose on the relationships between genetic variants of SOD2 and the susceptibility of lean NAFLD in the elderly Chinese Han population. Methods: Data in this manuscript were collected in a cross-sectional study among 5,387 residents (aged ≥60 years) in the Zhangjiang community center, Shanghai, China, in 2017. Ten (single nucleotide polymorphisms) SNPs previously reported to be related to NAFLD and obesity, including rs9939609, rs1421085, rs9930506, rs626283, rs641738, rs4880, rs58542926, rs738409, rs2281135, and rs2294918 were genotyped. The associations between genetic variations in SOD2 and fasting glucose in five genetic models were analyzed with the SNPassoc R package and rechecked with regression analysis. Mediation models were conducted to explore whether fasting glucose can mediate the association between SNPs and the susceptibility of lean NAFLD. Results: In this study, lean NAFLD individuals had a higher waist circumference and waist-to-hip ratio, ALT, and fasting glucose than lean non-NAFLD individuals (p < 0.050). In comparison, the AA genotypic frequency of rs4880 in SOD2 gene was much lower in lean NAFLD patients (p = 0.005). And rs4800 had a significant indirect effect on lean NAFLD incidence mediated by fasting glucose (p < 0.001). Conclusion: For the first time, the mediation effect of fasting glucose on the association of rs4880 in SOD2 with the susceptibility of lean NAFLD was clarified in the elderly Chinese Han population. It emphasized the connection between glucose homeostasis and oxidative stress in the mechanisms of lean NAFLD.

Keywords: SOD2 gene; fasting glucose; genetic variants; lean non-alcoholic fatty liver disease; mediation effect.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
The mediation effect of fasting glucose on the association between rs4880 and the risk of lean NAFLD. CI: Confidence interval; Nonalcoholic fatty liver disease; SOD2: Superoxide dismutase 2.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Al-Serri A., Anstee Q. M., Valenti L., Nobili V., Leathart J. B., Dongiovanni P., et al. (2012). The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies. J. Hepatol. 56, 448–454. 10.1016/j.jhep.2011.05.029 - DOI - PubMed
    1. Aneni E. C., Bittencourt M. S., Teng C., Cainzos-Achirica M., Osondu C. U., Soliman A., et al. (2020). The risk of cardiometabolic disorders in lean non-alcoholic fatty liver disease: A longitudinal study. Am. J. Prev. Cardiol. 4, 100097. 10.1016/j.ajpc.2020.100097 - DOI - PMC - PubMed
    1. Anstee Q. M., Darlay R., Cockell S., Meroni M., Govaere O., Tiniakos D., et al. (2020). Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort. J. Hepatol. 73, 505–515. 10.1016/j.jhep.2020.04.003 - DOI - PubMed
    1. Charatcharoenwitthaya P., Lindor K. D. (2007). Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin. Liver Dis. 11, 37–54. viii. 10.1016/j.cld.2007.02.014 - DOI - PubMed
    1. Chen F., Esmaili S., Rogers G. B., Bugianesi E., Petta S., Marchesini G., et al. (2020a). Lean NAFLD: A distinct entity shaped by differential metabolic adaptation. Hepatology 71, 1213–1227. 10.1002/hep.30908 - DOI - PubMed

LinkOut - more resources